These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 87456)

  • 1. Specific inhibition of human lymphocyte responses by primed autologous lymphocytes. I. Evaluation of MLR inhibition as a model for suppression.
    Sheehy MJ; Mawas C; Charmot D
    J Immunol; 1979 Jun; 122(6):2198-203. PubMed ID: 87456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man.
    Engleman EG; McDevitt HO
    J Clin Invest; 1978 Mar; 61(3):828-38. PubMed ID: 147885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR-specific suppressor cells after repeated allogeneic sensitizations of human lymphocytes in vitro.
    Sasportes M; Fradelizi D; Dausset J
    Transplant Proc; 1978 Dec; 10(4):905-9. PubMed ID: 83724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative responses to a nonspecific factor produced by irradiated stimulating cells can simulate antigen-specific secondary responses in the primed lymphocyte test.
    Reitnauer PJ; Brown LR; Hank JA; Sondel PM
    J Immunol; 1983 Jul; 131(1):165-70. PubMed ID: 6190905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human mixed lymphocyte culture stimulation by anti-HLA-D-associated antisera: studies with primed responding cells.
    Hirschberg H; Albrechtsen D; Solheim BG; Thorsby E
    Eur J Immunol; 1977 Jan; 7(1):26-9. PubMed ID: 139314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Ia-like DRw lymphocyte antigens stimulating activity in primary mixed lymphocyte reaction.
    Fradelizi D; Nunez-Roldan A; Sasportes M
    Eur J Immunol; 1978 Feb; 8(2):88-93. PubMed ID: 77783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
    Koide J; Engleman EG
    J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of antigen-specific suppressor T lymphocytes in man involves dual recognition of self class I MHC molecules and Leu-4/T3-associated structures on the surface of inducer T lymphocytes.
    Damle NK; Mohagheghpour N; Engleman EG
    J Immunol; 1984 Sep; 133(3):1235-40. PubMed ID: 6205073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.
    Hess AD; Tutschka PJ; Santos GW
    J Immunol; 1982 Jan; 128(1):355-9. PubMed ID: 6459374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interferon and radiation dose on the suppressive activity of human lymphocytes primed with allogeneic cells in mixed lymphocyte cultures.
    Aebersold P; Chen B; Sondel PM
    J Biol Response Mod; 1985 Jun; 4(3):251-7. PubMed ID: 3160831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.
    Yoshizawa K; Yano A
    J Immunol; 1984 Jun; 132(6):2820-9. PubMed ID: 6202762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic activity of antigen receptors artificially incorporated onto B lymphocytes.
    Peacock JS; Londo TR; Roess DA; Barisas BG
    J Immunol; 1986 Sep; 137(6):1916-23. PubMed ID: 2427584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of suppressor cells in the autologous mixed lymphocyte reaction.
    Fitzharris P; Knight RA
    Clin Exp Immunol; 1981 Oct; 46(1):185-95. PubMed ID: 6461452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the human allogenetic response in vitro with primed lymphocytes and suppressive supernates.
    Sasportes M; Wollman E; Cohen D; Carosella E; Bensussan A; Fradelizi D; Dausset J
    J Exp Med; 1980 Aug; 152(2 Pt 2):270s-283s. PubMed ID: 6447744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary MLC responses of primed lymphocytes after selective sensitization to non-HLA-D determinants.
    Wank R; Schendel DJ; Blanco ME; Dupont B
    Scand J Immunol; 1979; 9(6):499-505. PubMed ID: 88755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.